UPMC CHILDRENS HOSPITAL OF PGH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.7M
- Transactions
- 1,135
- Companies
- 40
- Average per transaction
- $3,249
Who reported the payments
| AstraZeneca | $1,577,028 |
| Takeda Pharmaceuticals U.S.A., Inc. | $966,104 |
| Zevra Therapeutics Inc | $196,423 |
| Insulet Corporation | $141,350 |
| Amicus Therapeutics, Inc. | $108,543 |
| Foundation Medicine, Inc. | $102,500 |
| Acadia Pharmaceuticals Inc | $94,133 |
| Pfizer | $81,872 |
| Merck | $62,262 |
| Medtronic | $53,942 |
| Tandem Diabetes Care, Inc. | $42,125 |
| National Marrow Donor Program | $39,680 |
| Novo Nordisk AS | $23,675 |
| Heron Therapeutics, Inc. | $22,773 |
| Vitalant | $22,100 |
| Philips North America LLC | $21,303 |
| Sanofi | $16,800 |
| Paragonix Technologies, Inc. | $11,295 |
| Biomarin Pharmaceutical Inc. | $9,483 |
| Amgen | $7,306 |
| Bayer | $7,000 |
| Olympus America Inc. | $6,548 |
| Alcresta Therapeutics, Inc. | $6,500 |
| Stryker | $5,728 |
| KARL Storz Endoscopy-america | $5,521 |
| Boehringer Ingelheim Italia S.p.a. | $5,039 |
| Ironwood Pharmaceuticals, Inc | $5,000 |
| Regeneron Healthcare Solutions, Inc. | $5,000 |
| Itxm Diagnostics | $4,420 |
| Boehringer Ingelheim France S.a.s. | $4,057 |
| Cochlear Americas | $3,985 |
| Eli Lilly | $3,370 |
| Boehringer Ingelheim International GmbH | $3,261 |
| Boehringer Ingelheim | $3,166 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $2,957 |
| Inspire Medical Systems, Inc. | $2,650 |
| Atos Medical Inc | $2,500 |
| Abbott | $2,500 |
| Medical Device Business Services, Inc. | $2,500 |
| Leadiant Biosciences, Inc. | $1,750 |